Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesTherapeutic delay reduces survival of rectal cancer but not of colonic cancer
British Journal of Surgery, 09/29/09
Iversen LH et al. – A total therapeutic delay of at least 60 days was a negative prognostic factor for long–term survival from rectal cancer.
Related Articles
Local Excision After Preoperative Chemoradiation Results in an Equivalent Outcome to Total Mesorectal Excision in Selected Patients with T3 Rectal Cancer
Annals of Surgical Oncology, 10/26/09
Relevance Score: 67%
Thymidine phosphorylase to dihydropyrimidine dehydrogenase ratio as a predictive factor of response to preoperative chemoradiation with capecitabine in patients with advanced rectal cancer
Journal of Surgical Oncology, 11/02/09
Relevance Score: 66%
Rectal endosonography: just how good are we at its interpretation
International Journal of Colorectal Disease, 10/27/09
Relevance Score: 66%
Circumferential resection margin as a prognostic factor in rectal cancer
British Journal of Surgery, 10/23/09
Relevance Score: 66%
Locally Recurrent Rectal Cancer: Prognostic Factors and Long-Term Outcomes of Multimodal Therapy
Annals of Surgical Oncology, 10/20/09
Relevance Score: 65%
Today in Colorectal Cancer/Polyps...keeping you current
Receive free subspecialty "5-minute updates" via email
EORTC Elderly Task Force experts opinion for the treatment of colon cancer in older patients
Cancer Treatment Reviews, 12/04/09
Bevacizumab combined with chemotherapy for patients with advanced colorectal cancer: a systematic review
Annals of Oncology, 12/04/09
A phase I study of axitinib (AG-013736) in combination with bevacizumab plus chemotherapy or chemotherapy alone in patients with metastatic colorectal cancer and other solid tumors
Annals of Oncology, 12/04/09
Sponsor
Article Search
Sponsor